ABSTRACT
Newly recognized pandemic infectious disease COVID-19 (Corona-virus disease) is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). This viral infection causes hypercoagulability and inflammation leading to increased incidence of both arterial and venous thrombotic events (VTEs). Therefore, patients infected with this novel virus seem to be at higher risk of thrombotic events (TEs) resulting in thromboembolic diseases, especially stroke and pulmonary embolism, or even cerebral venous sinus thrombosis (CVST). We report a case of 42-year-old female, presented with features of venous thrombotic events (extensive dural venous sinus thrombosis) and was subsequently found to have COVID-19 positive by reverse transcriptase-polymerase chain reaction (RT-PCR) test. The case report indicates CVST might be an unusual manifestation of COVID-19. Cerebral venous sinus thrombosis even presents as an initial symptom of COVID-19 without significant respiratory symptoms. Early diagnosis and treatment with thrombolytic agent in case of SARS-CoV-2 infection result in reduced morbidity and mortality. We recommend further studies to establish SARS-CoV-2 virus (the COVID-19 disease) as a known risk factor for CVST. © 2020 The author (s).
ABSTRACT
Globally, millions of documented SARS-CoV-2 infections with hundreds of thousands of deaths already reported. The majority of the fatal events have been reported in adults older than 70 years and those who have multiple co-morbidities. Despite the misery fatality of the virus, a significant number of peoples recovered from critical conditions also. Mild cases improved significantly with symptomatic management with strict maintenance of isolation. Therefore, many people believed that COVID-19 is a short-term illness, mild cases recovered completely within 2 weeks and severe or critical illness may require 3-6 weeks for complete recovery. However, the latest issue coming forward is delayed recovery in the surviving patients from severe or moderate COVID presenting with multisystem complications. We reported two cases of post COVID complications, newly named as "long COVID syndrome". We described the common symptoms two patients experienced following recovery from acute phase of COVID-19 and how they were managed. We also discussed on the pathogenesis and management plan of common symptoms persisting after recovery of COVID-19.
ABSTRACT
COVID-19 pandemic is an ongoing global pandemic which has caused unprecedented disruptions in the public health sector and global economy. The virus, SARS-CoV-2 is responsible for the rapid transmission of coronavirus disease. Due to its contagious nature, the virus can easily infect an unprotected and exposed individual from mild to severe symptoms. The study of the virus's effects on pregnant mothers and neonatal is now a concerning issue globally among civilians and public health workers considering how the virus will affect the mother and the neonate's health. This paper aims to develop a predictive model to estimate the possibility of death for a COVID-diagnosed mother based on documented symptoms: dyspnea, cough, rhinorrhea, arthralgia, and the diagnosis of pneumonia. The machine learning models that have been used in our study are support vector machine, decision tree, random forest, gradient boosting, and artificial neural network. The models have provided impressive results and can accurately predict the mortality of pregnant mother's with a given input. The precision rate for 3 models(ANN, Gradient Boost, Random Forest) is 100% The highest accuracy score(Gradient Boosting, ANN) is 95%, highest recall(Support Vector Machine) is 92.75% and highest f1 score(Gradient Boosting, ANN) is 94.66%. Due to the accuracy of the model, pregnant mother can expect immediate medical treatment based on their possibility of death due to the virus. The model can be utilized by health workers globally to list down emergency patients, which can ultimately reduce the death rate of COVID-19 diagnosed pregnant mothers. © 2021 IEEE.
ABSTRACT
PURPOSE: The major objectives of the study were to assess the knowledge, attitude & practice (KAP) towards community preparedness and response on prevention of COVID-19 among the community. METHOD: A sample survey was conducted to collect data from people admitted in a district level tertiary hospital for treatment of various health complications during COVID-19 pandemic. A total of 300 randomly selected patients and their attendants were interviewed in the hospital setting. RESULTS: The mean knowledge score was 18.73 out of 24 and the main sources of information were TV (86.5%), radio (13%), newspaper (13%), social media (13.5%), friends/relatives (14%), formal healthcare providers (6%) and religious leaders (3%). Knowledge was significantly poor among aged people, women, less educated and those on low incomes. The Majority of participants (79%) suggested wearing facemasks as effective tools to prevent COVID-19 from spreading, 56% mentioned maintaining of physical or social distance as crucial to prevent the infection. We found strong relationship between monthly total family expenses and wearing of facemasks by gender to prevent the COVID-19 (x2= 18.405;Cramer's V= .17, df = 8;sig;P= < .018). Similarly maintaining physical/social distance to prevent COVID-19 is also related to respondents' economic strata (x2= 43.741;Cramer's V= .14, df = 20;Sig;P= < .002). CONCLUSIONS: An awareness program on COVID-19 is very important to prevent the spread of the virus. Effective communication intervention with increasing treatment facilities is essential for prevention and control of COVID-19. Government and development agencies should prioritize the COVID-19 response program with regular health care services.
ABSTRACT
COVID-19 (Corona virus disease 2019), which starts from Wuhan, China on December, 2019 spread rapidly to different countries of the world including Bangladesh. It affects huge impact on health care system. It's a new disease with multisystem involvement. Physicians are experiencing new presentation of different cases and rare complication including arterial thrombosis. Few data is available regarding arterial thrombosis in SARS-CoV-2 infected patients. We are currently fighting with a 60 year old lady suffering from COVID-19 pneumonia with other co-morbidities developed severe arterial occlusion of right leg despite of taking anti platelet for long time for another cause. Patient developed irreversible right lower limb ischemia not improving with continuous infusion of unfractionated heparin followed by severe pulmonary embolism. So further study and recommendations will need to evaluate the cases and treatment in COVID-19 Patients with rare presentation.